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Abstract
Background: Brachyspira species are fastidious anaerobic microorganisms, that infect the colon of various animals. The
genus contains both important pathogens of livestock as well as commensals. Two species are known to infect humans: B.
aalborgi and B. pilosicoli. There is some evidence suggesting that the veterinary pathogenic B. pilosicoli is a potential
zoonotic agent, however, since diagnosis in humans is based on histopathology of colon biopsies, species identification is
not routinely performed in human materials.
Methods: The study population comprised 57 patients with microscopic evidence of Brachyspira infection and 26 patients
with no histopathological evidence of Brachyspira infection. Concomitant faecal samples were available from three infected
patients. Based on publically available 16S rDNA gene sequences of all Brachyspira species, species-specific primer sets were
designed. DNA was extracted and tested by real-time PCR and 16S rDNA was sequenced.
Results: Sensitivity and specificity for identification of Brachyspira species in colon biopsies was 100% and 87.7%
respectively. Sequencing revealed B. pilosicoli in 15.4% of patients, B. aalborgi in 76.9% and a third species, tentatively
named ‘‘Brachyspira hominis’’, in 26.2%. Ten patients (12.3%) had a double and two (3.1%) a triple infection. The presence of
Brachyspira pilosicoli was significantly associated with inflammatory changes in the colon-biopsy (p = 0.028).
Conclusions: This newly designed PCR allows for sub-differentiation of Brachyspira species in patient material and thus
allows large-scaled surveillance studies to elucidate the pathogenicity of human Brachyspira infections. One-third of
affected patients appeared to be infected with a novel species.
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Introduction
Brachyspiraceae are fastidious anaerobic spirochaetes and are
the causative agents of intestinal spirochaetosis, a condition that is
characterized by the attachment of Brachyspira species to the
colonic mucosa.
In animals, Brachyspira pilosicoli, B. hyodysenteriae, B. intermedia and
B. alvinipulli can cause serious disease[1–3], whereas B. innocens and
B. murdochii are considered harmless commensals of the gut-flora.
[4] Brachyspira pilosicoli infects a wide range of mammals, including
humans [5,6], and is the undisputed etiological agent of porcine
intestinal spirochaetosis [3,7], and a well known pathogen causing
diarrhoea and dysentery in pigs and chickens.[8–10] In humans
thus far only two infecting species have been reported in detail:
Brachyspira aalborgi (which is found exclusively in humans and
higher primates) [11,12] and B. pilosicoli (suggesting putative
zoonotic potential of B. pilosicoli). [8,13] Additionally, there is
limited molecular evidence of a third Brachyspira species that
awaits formal confirmation.[14–17] Jensen et al. [15] used
fluorescent in situ hybridization to identify an uncharacterised
Brachyspira species and proposed the name ‘‘Brachyspira christiani’’,
but since they did not sequence 16S rDNA, it can not be
ascertained that this species is the same as the species describe by
Pettersson et al. [16] We therefore propose to refer to the species
described in this paper as ‘‘Brachyspira hominis’’, as it has currently
only been described in humans.
Symptoms commonly associated with human intestinal spir-
ochaetosis are chronic diarrhoea, abdominal pain, weight loss,
faecal mucus and blood-stained faeces but the clinical relevance of
these findings has been debated.[18–20] Invasive spirochaetaemia
has been reported in critically ill and/or immuno-compromised
patients. [21,22].
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The pathogenic potential of these bacteria in humans has never
been thoroughly investigated. Due to the strict anaerobic growth
requirements and long incubation times it is difficult to routinely
culture Brachyspira species. [12,23] Therefore, routine diagnosis
of human intestinal spirochaetosis is currently only based on
histopathology of colonic biopsies (figure S1) and the absence of
distinct morphological hallmarks prohibit the discrimination
between pathogenic and non-pathogenic Brachyspira species. In
addition, the invasive nature of colonoscopy limits epidemiological
as well as non-invasive clinical follow-up studies. As a result not
much is known on the species distribution of Brachyspiraceae in
human infections. Based on histopathological examination of
colon biopsies obtained for various reasons the estimated
prevalence in the general Western population varies from 1.1%
to 6.9%, with higher incidences among immunocompromised
patients.[24–26] Some studies have been performed using species-
specific primers, investigating the epidemiology of B. aalborgi and
B. pilosicoli in humans. Based on these, B. aalborgi causes human
infection more frequently (80%–88.6%) than B. pilosicoli (5.7%–
14.3%), however, no data exists on infections with ‘‘B. homi-
nis’’.[27–29].
Several PCRs for detecting Brachyspira in faecal or cadaver
specimens of animals have been published. [30] These are neither
validated for human diagnostic use, nor allow for immediate
species determination. To our knowledge, only one PCR has been
described for use on human faeces. [31] However, due to the size
of the amplified fragment, this PCR is neither suited for use on
formalin-fixed paraffin-embedded biopsy samples nor does it allow
for real-time species identification. In addition, these PCRs have
been species specific, thus only amplifying 16S rDNA from one
species and do not allow for the identification of multi-infections
with hitherto unknown Brachyspira species.
Aims of this Study
In this study we will describe the design and validation of a real-
time PCR allowing species differentiation of Brachyspira species in
Table 1. Primer sets, length of amplicon, annealing temperature, extension time and PCR-protocol.
Primer set Name 59–––39
Total
length uC Time Purpose
Bspp Bspp F TggACTAATACCgCATATACTCTT 82bp 55 20s Species discrimination
Bspp R TAggCCgCAggCTCAT
PhHV PhHV F gggCgAATCACAgATTgAATC 89bp 55 20s DNA extraction control
PhHV R gCggTTCCAAACgTACCAA
b-globulin GH20 gAAgAgCCAAggACAggTAC 268bp 62 60s DNA quality control
PC04 CAACTTCATCCACgTTCACC
Step A StepA F TggATAAgTTAgCggCgAACTg 212bp 62 60s First 16S sequencing primer
StepA R TCAggTCggCTACCTATCg
Step B StepB F gAgCCTgCggCCTATTAgC 253bp 62 60s Second 16S sequencing primer
StepB R gCCgAggCTTACATTATCTACTgTC
Step C StepC F AgCgACATCgCgTgAgg 258bp 62 60s Third 16S sequencing primer
StepC R TCCATCATCCCCTACAATATCCAAg
Pilo-A Pilo F AgTTTTTTCgCTTCACgATgAg 90bp 62 60s B. pilosicoli 16S amplification
StepA R TCAggTCggCTACCTATCg
A-Pilo StepA F TggATAAgTTAgCggCgAACTg 145bp 62 60s B. pilosicoli 16S amplification
Pilo R gCTCATCgTgAAgCgAAAAAAC
Aalb-A Aalb F gACgCTAAAgCgTAgTAgAgg 113bp 62 60s B. aalborgi 16S amplification
StepA R TCAggTCggCTACCTATCg
A-Aalb StepA F TggATAAgTTAgCggCgAACTg 120bp 62 60s B. aalborgi 16S amplification
Aalb R CCTCTACTACgCTTTAgCgTCA
Homi-A Homi F CTCTTgACACATAAgTgTAgTAgAg 118bp 62 60s ‘‘B. hominis’’ 16S amplification
StepA R TCAggTCggCTACCTATCg
A-Homi StepA F TggATAAgTTAgCggCgAACTg 120bp 62 60s ‘‘B. hominis’’ 16S amplification
Homi R CCTCTACTACACTTATgTgTCAAgAg
PCR conditions
Primer concentration: 2,5 mM of both forward and reverse primers.
Buffer composition: LightCyclerH 480 SYBR Green I Master.
PCR volume
15 ml buffer and 5 ml DNA-eluate per PCR.
PCR consumables
White 96-well plate (Roche Diagnostics, Almere, The Netherlands) sealed with transparent self-adhesive foil (Roche Diagnostics, Almere, The Netherlands).
PCR protocol
Pre-incubation at 95uC for 10 minutes, de-annealing at 95uC for 10 seconds, 10 seconds annealing at the above-specified temperature, amplification at 72uC for the
above specified time, 45 cycles. Melting-curve analysis: 5 seconds at 95uC, one minute at 65uC, 2.2uC per second increase of temperature until 97uC with five acquisitions
per degree Celsius.
doi:10.1371/journal.pone.0052281.t001
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formalin fixed paraffin tissue specimens and faeces. In addition we
investigate species distribution and symptoms in a cohort of
patients with histologically documented Brachyspira infection.
Methods
Ethics Statement
Patients visiting a Dutch hospital are actively informed of the
‘opt-out’ system regarding research on archival patient material.
Dutch law requires all studies using such materials to obtain an
official approval by the local ethics committee. This study was
approved by the Medical Ethics Testing Committee of the
University Medical Centre Utrecht, The Netherlands, under
protocol number 11-402/C. Only material from patients who did
not opt-out has been included in this study.
Sample Selection
Formalin-fixed paraffin-embedded (FFPE) colon tissue taken
between 2001 and 2011 was retrospectively identified in four
Dutch hospitals (two regional hospitals (Tergooiziekenhuizen,
Blaricum/Hilversum and St. Antonius Hospital, Nieuwegein) and
two large academic centres (the University Medical Centre,
Figure 1. Schematic representation of the relative position of the Brachyspira primers and resultant PCR fragments. Numbering and
fragment sizes according to the 16S sequence of the type strain of B. aalborgi (NCTC 11492). Fragment names refer to Table 1.
doi:10.1371/journal.pone.0052281.g001
Figure 2. Example of the melting-curve analysis. There is a clear difference in melting-temperature between the type-strain of B. pilosicoli and
B. aalborgi. Biopsy samples containing these species fall neatly within these graphs (patients #13 and #23). ‘‘B. hominis’’ (patient #14) is visible as
a peak between the type strains, indicating a different base-pair composition. The double infection (patient #26) begins as a B. pilosicoli-peak with
a clear shoulder under the ‘‘B. hominis’’ peak, indicating that two different DNA molecules are present, each with a different melting-temperature-
peak. The triple infection (patient #41) is displayed here by the biopsy sample that had both a B. pilosicoli and a B. aalborgi, another biopsy sample
taken from this patient at the same time indicated an infection with ‘‘B. hominis’’ (data not shown).
doi:10.1371/journal.pone.0052281.g002
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Utrecht and Vrije Universiteit Medical Centre, Amsterdam).
Samples were included if the pathology report reported the
presence of spirochaetosis and if this was confirmed by immuno-
histochemistry (Borrelia burgdorferi (Lyme) IgG antiserum, ILP 0301,
ImmunoLogic, Duiven, The Netherlands). This staining is based
on the immunological cross-reactivity of a universal spirochaete
antigen and is used routinely in most Dutch laboratories to
confirm the diagnosis of spirochaetes in histological samples. As
control samples, spirochaete negative colon biopsies, taken
between January 2009 and December 2010, were selected if tissue
quality was macroscopically good and no spirochaetes were
detected by immunohistochemistry.
All colon-biopsy materials were revised by two experienced
gastrointestinal pathologists (MEIS and HVS), who were unaware
of the initial diagnosis and PCR-results. The presence or absence
of inflammatory cells in spirochaete-positive biopsy samples was
scored by one pathologist (HVS). Where possible, relevant clinical
data were retrieved from clinical files of patients with Brachyspira
infection (i.e., sex, age at time of biopsy, indication for biopsy,
HIV-status, and presence or absence of rectal blood loss,
diarrhoea, abdominal pain, weight loss or faecal mucus).
From three patients, faecal samples were obtained. DNA from
these samples was isolated using the same protocol as for the FFPE
samples, and further analysis was identical to the colon biopsies.
Processing of FFPE Biopsy Samples
Of each FFPE-sample, three 4 mm sections were cut for
pathological evaluation, and, subsequently, five 20 mm sections
were cut and placed in a 1,5 ml Eppendorf tube (Eppendorf,
Hamburg, Germany), and three additional control sections were
cut (4 mm). The knife was then discarded and the microtome
thoroughly cleaned with 96% ethanol to prevent the next FFPE-
sample to be contaminated with DNA from the previous sample.
The five 20 mm sections were frozen at 280uC until DNA
isolation. The six 4 mm sections were fixed on glass slides and
archived at room temperature.
DNA-isolation
DNA-isolation from FFPE samples was performed by standard
procedures. These consisted of the removal of the paraffin material
through several wash steps followed by automated DNA extrac-
tion. The first wash step consisted of adding 1 ml of xylene and
fifteen minutes incubation in a shaking heat block (1,400 rpm,
22uC). The samples were then centrifuged at 13,000 g for five
minutes and subsequently the xylene was removed. This xylene
wash-step was performed twice. Then 1 ml 96% ethanol was
added to the pellet and samples were vortexed for 5 seconds.
Subsequently, samples were centrifuged at 13.000 g for five
minutes after which the ethanol was discarded. The ethanol
wash-step was performed twice. The final wash-step consisted of
adding 1 ml acetone, vortexing for 5 seconds, centrifuging at
13.000 g for 5 minutes and carefully removing the acetone. The
pellet was then allowed to dry for 30 seconds at room temperature.
Subsequently, 360 ml digestion buffer (10 mM hydroxymethyl-
aminomethane, 1 mM ethyleendiamine tetracetic acid, 0.001%
sodium dodecyl sulphate and 0.5% Triton X 100) and 20 ml
protein K (600 U/ml, Roche Diagnostics, Almere, The Nether-
lands) was added to the pellet. Finally 40 ml Phocine Herpes Virus
(PhHV) DNA was added as an internal control to monitor the
DNA isolation and PCR amplification processes. [32] The
resultant suspension was placed in a shaking heat block
(750 rpm, 70uC) for 30 minutes to allow digestion of tissue and
subsequently incubated at 95uC for 15 minutes and 750 rpm to
inactivate the protein K. The samples were then stored at 280uC
until DNA isolation. DNA was isolated using the MagNA Pure
96 DNA and Viral NA Small Volume Kit on a Roche
MagnaPure96 (Roche Diagnostics, Almere, The Netherlands)
with the Viral NA Universal SV extraction protocol according to
the manufacturer’s instructions.
For the isolation of DNA from faecal samples a suspension of
25 mg faeces in 200 ml lysis buffer (cobasH PCR Female Swab
Sample Kit, Roche Diagnostics, Mannheim, Germany) was
prepared and spiked with 40 ml PhHV DNA, mixed well and
placed at 280uC for more than 2 hours. The frozen solution was
then incubated at 95uC for 30 minutes and DNA was extracted
using the MagNA Pure 96 DNA and Viral NA Small Volume Kit
on a Roche MagnaPure96 (Roche Diagnostics, Almere, The
Netherlands), with the Viral NA Universal SV extraction protocol
according to the manufacturers instructions.
Primer-design
Sequences of the small ribosomal subunit DNA of all
Brachyspira species and Staphylococcus aureus (ATCC 12600;
S000529044), Peptostreptococcus anaerobius (NCTC 11460;
S000140702), Bacteroides fragilis (ATCC 25285; S000528922),
Bifidobacterium longum (ATCC 15697; S000414117), Escherichia coli
(ATCC 11775T; S000004313), Pseudomonas aeruginosa (DSM50071;
S000010427), Borrelia burgdorferi (ATCC 35210; S000436531) and
the 18S of Candida albicans (GenBank ID 4512045), Zae mays
(GenBank ID 6273844) and Homo sapiens (GenBank ID M10098.1)
were retrieved from the Ribosomal Database Project (release 10,
update 22, August 30, 2010) [33] and GenBank (Release 181.0
(14/12/2010)) and aligned using Seaview (version 4.2.8). [34,35]
Four Brachyspira-specific primer-sets were designed based on this
alignment (table 1) and analysed in silico for undesirable targets
with the Probe Match function of the Ribosomal Database Project
and the Primer-BLAST-algorithm. [36] This primer-set was
designed to amplify an 82 base-pair region that is specific for
both B. pilosicoli, B. aalborgi, and the putative ‘‘B. hominis’’ with the
conditions that 1) the primer binding sites are conserved in all
Brachyspira species to ensure that all Brachyspira species will be
amplified, and 2) the primer binding sites differ sufficiently in
Table 2. Comparison of melting-curve prediction to sequence result*.
Melting-curve prediction Sequence result
B. pilosicoli (n = 7) ‘‘B. hominis’’ (n =7) B. aalborgi (n =41)
B. pilosicoli (n = 9) 7 2 0
‘‘B. hominis’’ (n = 11) 0 5 6
B. aalborgi (n = 35) 0 0 35
*Multi-infections are not shown in this table, since all multi-infections were predicted correctly.
doi:10.1371/journal.pone.0052281.t002
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sequence from all other known bacterial 16S rDNA sequences so
that only 16S from Brachyspira species will be amplified, and 3)
the region between these primers differs in length and/or base-pair
composition between the three human Brachyspira species thus
generating sufficient differences in melting-temperatures of the
PCR fragments, allowing for a melting curve based species
identification. This was verified with Clone Manager 9 Pro-
fessional Edition (version 9.0), which uses the expression by Freier
et al. [37] Subsequently, this theoretical difference was confirmed
using the available human reference strains (B. pilosicoli (WesB) and
B. aalborgi (513AT). Since ‘‘B. hominis’’ has only been described
molecularly no (type or reference) strains where available, and
therefore it was not possible to test the correctness of the ‘‘B.
hominis’’ melting temperature prediction.
Three sets were designed for the generation of Brachyspira
specific 16S rDNA fragments thus allowing to obtain the
sequences of the first 517bp of 16S rDNA (StepA, StepB and
StepC) of the infecting Brachyspira species from the DNA isolated
from the biopsies.
Based on results obtained in this study, six primer sets were
designed to allow for the generation of Brachyspira species-specific
16S rDNA fragments in double-infected samples for sequencing
(Pilo-A, Aalb-A, Homi-A, A-Pilo, A-Aalb and A-Homi). All
primer-sets are shown in table 1 and figure 1.
PCR reactions were performed in a LightCycler 480 II PCR
machine (Roche Diagnostics, Almere, The Netherlands) according
to the manufactures instructions and PCR conditions and primers
are summarized in table 1 and figure 1. All primers were
synthesized by TIB MOLBIOL GmbH, Berlin, Germany. All
samples were tested twice in independent PCRs.
Controls and DNA amplification. In addition to the PhHV
as a control for the amplification and isolation of DNA,
a commonly used and validated b-globulin primer-set was used
as control for the successful isolation of DNA from spirochaete-
negative FFPE-samples. [38] DNA from the type strains B.
hyodysenteriae (B-78; ATCC 27164), B. innocens (B256; ATCC
29768), B. aalborgi (513A; NCTC 11492), B. pilosicoli (P43/6/78;
ATCC 51139 and WesB), B. intermedia (PWS/A; ATCC 51140), B.
murdochii (56–150; ATCC 51284) and B. alvinipulli (C1; ATCC
51933) (kindly donated by dr. D.J. Hampson and dr. T. La,
Murdoch University, Perth, Australia) were used as controls. PCR
amplification and melting-curve analysis was performed on
a Roche LightCycler 480 II (Roche Diagnostics, Almere, The
Netherlands) using the protocol supplied in table 1. SYBR-green
based melting-curves were generated to assess the Tm of the PCR-
product were generated with the LightCyclerH 480 Software
(version 1.5.0.39).
Sequencing
To allow for the sequencing of the Brachyspira species three
primer-sets (Step A, B and C; table 1, figure 1) were designed, that,
when assembled, cover the first 517bp of the 16S rDNA. In case of
a double infection, species-specific primers (table 1) were used to
generate separate PCR products for the individual Brachyspira
species predicted to be present in these samples. Sequencing of the
PCR products was performed using the BigDye Terminator v1.1
technique on a 3730 DNA Analyser (Applied Biosystems,
Carlsbad, California, United States of America) according to the
manufactures instructions. Sequences were manually assembled
Figure 3. Phylogenetic tree constructed of the first 517 unique
base pairs of all patient samples. The sequences published by
Pettersson and colleagues (Hcc, Hca Tva and Tvb) and the sequences of
the known type strains. The ‘‘B. hominis’’ group clearly differs
phylogenetically from the known type strains and falls within the
group described by Pettersson. Note that two patients (#6-II and #57))
are missing from this tree, since it proved to be impossible to sequence
the middle part of the first 517bp of the 16S rDNA. Borrelia burgdorferi
(ATCC 35210) was used as out-species.
doi:10.1371/journal.pone.0052281.g003
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using Chromas (version 2.33, Technelysium Pty Ltd, Australia)
and and Seaview (version 4.2.8) and compared with the known
sequences available through the Ribosomal Database Project and
BLAST-algorithm.
Construction of Phylogenetic Tree
The assembled sequences and the type strains from all
Brachyspira species obtained from the Ribosomal Database were
aligned with the aid of Seaview (version 4.2.8) [34,35,39] and
a phylogenetic tree was constructed from these alignments with
SplitsTree (version 4.11.3, built February 26, 2010) [40] using
Borrelia burgdorferi (ATCC 35210) as an out-species.
Results
PCR Validation
The Bspp and StepA-C sets amplified the expected regions in
the Brachyspira species type strains (B. hyodysenteriae (B-78; ATCC
27164), B. innocens (B256; ATCC 29768), B. aalborgi (513A; NCTC
11492), B. pilosicoli (P43/6/78; ATCC 51139 and WesB), B.
intermedia (PWS/A; ATCC 51140), B. murdochii (56–150; ATCC
51284) and B. alvinipulli (C1; ATCC 51933)). When evaluating the
melting curves for the Bspp primer-set, there appeared to be a clear
difference in melting curve temperature in all three human species
(figure 2). The species-specific sets only generated a product in B.
aalborgi (for Aalb-A and A-Aalb) and B. pilosicoli (for Pilo-A and A-
Pilo). For the ’’B. hominis’’-specific set, this could not be tested
in vitro, because to our knowledge no strains of ‘‘B. hominis’’ are
available.
PCR Results
Based on the inclusion criteria 63 FFPE-samples from 57
patients with Brachyspira infection and 28 control samples (from
28 patients) were retrieved. Patients with and without Brachyspira
infection had comparable age (46.2614.9 years and 47.4615.8 for
controls; p = 0.716) and sex distribution (p = 0.506). Thirteen
infected patients and one control had HIV (p= 0.009). Three
biopsies, from one infected and two controls, were excluded from
analysis because of negative internal control reactions. For both
FFPE and faecal samples, PCR data matched with histopatholog-
ical results.
Sequencing, Melting-curve Analysis and Phylogenetic
Analysis
The Bspp primer-set produced a product in all samples from
histopathologically positive patients and no product was produced
in negative controls. Interpretation of the melting-curves is shown
in table 2, compared to sequence results. With the exception of
two samples (patient 6-II and patients 57), all PCR-positive
samples were successfully amplified using primer-sets StepA-C,
thus allowing the assembly of the first 517bp of the 16S rDNA. Of
patients 6-II and 57, the central part (StepB) of the sequence could
not be amplified despite repeated attempts. However, the first (59-
)part could be obtained (StepA) and this contains the most species-
specific information, allowing for proper species identification.
Based on the sequence results, B. aalborgi was identified in 50
(76.9%), B. pilosicoli in 10 (15.4%) and ‘‘B. hominis’’ in 17 (26.2%)
samples. There were eight (12.3%) double infections and two
(3.1%) triple infections (table 2). The obtained sequences were
submitted to GenBank (accession numbers JX446497 through
JX446571, table S1). Using the complete 517bp 16S rDNA
sequences a phylogenetic tree (figure 3) was constructed, with the
addition of the sequences described by Pettersson and colleagues
(named Hca, Hcc, Tva and Tvb followed by a number). [16] In
this tree, two lineages consisting of novel Brachyspira sequences
can be indicated (as per Pettersson et al.: cluster 1 (B. aalborgi),
cluster 2 (‘‘B. hominis’’) and cluster 3 (Brachyspira species). Patient
44 differs from the type strain of B. aalborgi by 14 base-pairs, and is
closest related to Tvb03, with a difference of nine base-pairs.
When comparing sequence results to melting-curves, melting
curves correctly identified the species present in 57 of 65 FFPE
samples. In eight samples a double infection and in two samples
a triple infection was predicted and in all cases confirmed by
sequence analysis. No discrepancies were observed between the
duplicate PCRs of the samples. Misclassification occurred in eight
samples; six predicted ‘‘B. hominis’’ appeared B. aalborgi on
Table 3. Statistical Analyses of Clinical Data#.
B. pilosicoli (n = 6) B. aalborgi (n = 38) ‘‘B. hominis’’ (n = 11) p-value
Diarrhoea 5 (83,3%) 26 (68,4%) 5 (45,5%) 0,230
Abdominal pain 6 (100%) 24 (63,2%) 8 (72,7%) 0,185
Blood loss 4 (66,7%) 13 (34,2%) 3 (27,3%) 0,241
Weight loss 2 (33,3%) 10 (26,3%) 3 (27,3%) 0,938
Mucus 3 (50%) 11 (28,9%) 0 (0%) 0,781
HIV 2 (33,3%) 9 (23,7%) 2 (18,2%) 0,052
Inflammatory changes* 4 (57,1%) 7 (15,6%) 2 (13,3%) 0,028
Two or more complaints 5 (83,3%) 25 (65,8%) 8 (72,7%) 0,660
Three or more complaints 5 (83,3%) 15 (39,5%) 3 (27,3%) 0,071
Four or more complaints 3 (50%) 7 (18,4%) 1 (9,1%) 0,119
Five complaints 0 (0%) 2 (5,3%) 0 (0%) 0,629
#There were 8 patients with double infections (B. pilosicoli+‘‘B. hominis’’ n = 1; B. aalborgi+‘‘B. hominis’’ n = 7) and 2 with triple infection. These were analysed in all
groups.
Chi-squared test was used in all analyses.
Faecal samples were omitted from analyses.
*Inflammatory changes is calculated for all biopsy samples (B. pilosicoli n= 7; B. aalborgi n = 45 and ‘‘B. hominis’’ n = 15), since this could be established for all biopsy
samples.
doi:10.1371/journal.pone.0052281.t003
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sequence analysis and two predicted B. pilosicoli’s appeared ‘‘B.
hominis’’ (Table 2).
Correlation between the Infecting Species and Clinical
Symptoms
Clinical information was available from 49 patients with
Brachyspira infection (table 3). No significant associations were
found except that inflammatory changes were more frequently
observed in the presence of B. pilosicoli (p = 0.028; Chi-squared
test).
Discussion
We have designed a real-time PCR for species-specific
identification of Brachyspira species in formalin-fixed paraffin-
embedded material and faeces, which now allows large-scale
epidemiological studies of this human disease. The first analysis of
57 infected patients revealed a high prevalence of a novel species –
tentatively called – ’’B. hominis’’ and a large proportion of double
infections.
We designed a Brachyspira species-specific PCR targeting the
16S rDNA that can identify all Brachyspira species that have been
associated with infection in humans. Pettersson and colleagues
identified three groups of spirochaetes that were closely related to,
but based on 16S rDNA, phylogenetically different from,
Brachyspira aalborgi. [16] These findings have been confirmed, but
no epidemiological data exist. [14,15,17] Next to the 16S rDNA,
the NADH oxidase gene (NOX gene) is frequently used to identify
Brachyspira species. [41,42] Mikosza et al. investigated the novel
‘‘B. hominis’’ sequences from both veterinary and human sources
and sequenced the NOX gene. They found a topology very similar
to Pettersson et al. in both the 16S rDNA sequences and the NOX
gene. [17] Our results are in agreement with the results obtained
by both Pettersson et al. and Mikosza et al.
Several authors have remarked that the 16S rDNA genes of the
various Brachyspira species are highly similar, and that species
differentiation based solely on 16S is difficult. [17,43,44]
Therefore, finding a 16S sequence that differs from known species
is a strong indicator that this in fact is a novel Brachyspira species.
It is for this reason that the NOX gene is frequently used to
identify the species of Brachyspiraceae. The described primers by
Mikosza et al. target B. aalborgi and ‘‘B. hominis’’ sequences only,
not amplifying any other Brachyspira species, therefore limiting
direct species differentiation in human material, since B. pilosicoli
also occurs in humans. Further studies are needed to better classify
these novel sequences.
In 65 samples of 57 patients with histologically documented
Brachyspira-infection we identified 17 (26.2%) samples with this
novel 16S rDNA sequence of ‘‘B. hominis’’, suggesting that more
than the two hitherto described Brachyspira species are involved in
human intestinal spirochaetosis. Moreover, these novel sequences
were frequently (10/17; 58.8%) present in double- or even triple-
infections, which may explain why they have not frequently been
identified before. Our finding that this species was present as
a mono-infection in seven patients and as a co-infection with other
Brachyspira species in ten patients strongly suggest that this novel
Brachyspira species is capable of infecting humans. However,
more studies are needed to confirm these preliminary findings.
Ribosomal DNA sequencing is considered the gold standard in
species determination. Our Bspp PCR provides rapid information
with 100% accuracy for the presence (or absence) of Brachyspira
species, and with 87.7% accuracy (95% confidence interval 0.76–
0.94) for species identification. However, there were eight (out of
65; 12.3%) discrepancies between the predicted species based on
the melting-curve and the sequence result. The melting-curves rely
on a ,1uC difference between species (figure 2; ,79uC for B.
pilosicoli, ,80uC for ‘‘B. hominis’’ and ,81uC for B. aalborgi). There
are several known issues with SYBR-green. The Tm is influenced
by a variety of factors. [45] Impurities in the extracted DNA, and/
or higher concentrations of DNA might result in a minute shift of
the melting temperature: there were never any discrepancies
between the individual duplicates of samples. It is further
supported by the observation that the melting-curve never shifted
to the left, which would indicate a lower melting-temperature, but
always to the right, indicating a higher melting-temperature
(table 2). This is a known issue of SYBR-green based melting-
curves. [45].
We acknowledge that the only true way of definitively calling
a new species is to culture the bacterium. This is indeed a limitation
that we are currently unable to solve, as we could not culture
Brachyspira species from the formalin-fixed samples that were
retrospectively identified in this study.
Based on the three Brachyspira positive faecal samples that were
present in this study that could be correlated to positive biopsy
samples, we conclude that this PCR allows for the testing of faeces.
As this observation is based on concomitant material (biopsy and
faeces) of three patients only, further studies are needed.
Although the analysis of 49 patients with Brachyspira infections
suggested no correlation between species and physical complaints,
the high prevalence of double infections, the small sample size of
a the biased population (only patients of whom biopsies were taken
for analyses of gastro-intestinal complaints) precludes strong
conclusions on the clinical spectrum of disease caused by
Brachyspira species. However, in pigs and poultry, B. pilosicoli is
a known pathogen and the fact that the presence of B. pilosicoli was
significantly associated with inflammatory changes in the colon-
biopsy might suggest an immunologic reaction of the host against
B. pilosicoli. Since only 49 patients had complete clinical records,
no definitive pathogenic potential in humans can be attributed to
B. pilosicoli. Further research into this finding is necessary.
In conclusion, we designed a real-time PCR for the immediate
differentiation of Brachyspira species in human sample material,
allowing for epidemiological studies in formalin-fixed paraffin-
embedded material and faeces as well as routine, non-invasive
clinical follow-up. Using this PCR, we investigated the epidemi-
ology of the different Brachyspira species, and found a relatively
high incidence of the novel ‘‘B. hominis’’ and a large proportion of
double infections.
Supporting Information
Figure S1 Histopathological image of human intestinal
spirochaetosis. The spirochaetes are present as a ‘false brush
border’ on the mucosal surface of the entire colon, as indicated by
the arrow (haematoxylin and eosin stain, original magnification
630 times, bar equals 20 mm).
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